Clinical Trial Update: Safety and Efficacy of VDPHL01 in Males With AGA [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the safety and efficacy of VDPHL01 for androgenetic alopecia in males; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• VDPHL01

Snippet

Sponsor: Veradermics, Inc. | Conditions: Androgenetic Alopecia, AGA | Phase 3 | Status: ACTIVE_NOT_RECRUITING